Aptamer-Linked CRISPR/Cas12a-Based Immunoassay

Hui Li,Menglu Li,Yucai Yang,Fei Wang,Feng Wang,Chao Li
DOI: https://doi.org/10.1021/acs.analchem.0c04687
IF: 7.4
2021-01-26
Analytical Chemistry
Abstract:The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas system has shown great promising applications in the area of nucleic acid biosensing. However, because of the dearth of versatile signal transduction strategies, this system is usually compromised to low versatility, moderate sensitivity, and complex operation for non-nucleic acid targets, limiting its clinical transition. Herein, we describe a direct method to establish the correlation between non-nucleic acid analytes and the CRISPR/Cas12a system using a series of rationally designed, aptamer-flanked activator DNA strands, which enable ultrasensitive detection of biomarkers from different species, greatly broadening the possibility of the CRISPR/Cas system in bioanalysis. Meanwhile, the signal output is highly optional and the sensing principle is akin to the traditional enzyme-linked immunosorbent assay (ELISA), so it can be directly imposed on the currently available ELISA platform, further facilitating its application in medical diagnostics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c04687?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c04687</a>.Information of materials and instruments, sequence of the used nucleic acids, detailed detection procedures, HRP activity, modification of rQDs, effects of Mg<sup>2+</sup> ions on enzyme activity, commercial ELISA kit for PDGF-BB detection, characterization of the nanoprobe, adsorption of GNPs on a plate, amplification effect of using Apt-acDNA2, scheme of Opti-ALCIA and split ATP aptamer, and adsorption of the Cas12a complex on the cell membrane (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04687/suppl_file/ac0c04687_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
chemistry, analytical
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to directly detect non - nucleic - acid biomarkers using the CRISPR/Cas12a system in order to improve the detection sensitivity, simplicity and application range. The traditional CRISPR/Cas12a system has limitations such as complex signal transduction strategies, moderate sensitivity and complex operation when detecting non - nucleic - acid targets, which restricts its clinical application. The authors proposed an aptamer - linked CRISPR/Cas12a immunoassay method (ALCIA). By designing a series of reasonable activation DNA strands with aptamers, a direct connection between non - nucleic - acid analytes and the CRISPR/Cas12a system was established, achieving ultrasensitive detection of biomarkers of different species. This method not only expands the bioanalytical possibilities of the CRISPR/Cas system, but also its signal output is highly flexible, similar to the traditional enzyme - linked immunosorbent assay (ELISA), and can be directly applied to the existing ELISA platform, further promoting its application in medical diagnosis.